HDAC9 and Alzheimer disease: Additionally, several AD mouse models have been treated with HDAC inhibitors, such as sodium butyrate, trichostatin A, and valproic acid, showing improvements in learning and memory, some resulting from reduced Aβ levels (Sung et al., 2013).